SRJN (SRJN)

SRJN (SRJN) is a company listed on the NYSE.

As of Oct 23, 2026: returns 1 day -0.4%, 1 week -1.6%.

Surrozen, Inc. (SRZN) is a clinical-stage biotechnology company specialized in the development of tissue-specific antibodies designed to modulate the Wnt signaling pathway for repair and regeneration.

SRJN financial model: income statement, cash flow and balance sheet